Certara Strategic Consulting, a leading name in the biopharmaceutical industry, is headquartered in the United States, with significant operations across North America, Europe, and Asia. Founded in 2008, Certara has established itself as a pioneer in drug development and regulatory science, providing innovative solutions that enhance the efficiency of clinical trials and regulatory submissions. The company offers a range of core services, including pharmacokinetic modelling, simulation, and strategic regulatory consulting, which are distinguished by their integration of advanced technology and deep industry expertise. Certara's unique approach enables clients to make informed decisions throughout the drug development process, ultimately accelerating time to market. With a strong market position, Certara has achieved notable milestones, including collaborations with major pharmaceutical companies and contributions to numerous successful drug approvals. Their commitment to advancing drug development continues to set them apart in the competitive landscape.
How does Certara Strategic Consulting's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Certara Strategic Consulting's score of 43 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Certara Strategic Consulting, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Certara, Inc., which may influence its climate commitments and reporting practices. As of now, Certara Strategic Consulting has not established any documented reduction targets or climate pledges. The absence of specific initiatives or targets suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the lack of direct emissions data and reduction initiatives, it is essential for Certara Strategic Consulting to align with industry standards and best practices in climate action. This could involve setting science-based targets and participating in initiatives such as the Science Based Targets initiative (SBTi) to enhance its sustainability profile and commitment to reducing carbon emissions in the future.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 441,770 | 000,000 | 000,000 |
| Scope 2 | 1,127,010 | 000,000 | 000,000 |
| Scope 3 | - | 0,000,000 | 0,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Certara Strategic Consulting has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.